Interdisciplinary patient care in the intensive care unit: Focus on the pharmacist

Pharmacotherapy

Volumn 31, Issue 2, 2011, Pages 128-137

  Erstad, Brian L ^a   Haas, Curtis E ^c   O'Keeffe, Terence ^b   Hokula, Cheryl A ^c   Parrinello, Kathleen ^d   Theodorou, Andreas A ^b  

^a UNIVERSITY OF ARIZONA   (United States)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^d STRONG MEMORIAL HOSPITAL   (United States)

Author keywords

Critical care; ICU; Intensive care unit; Interdisciplinary team; Pharmacist's role

Indexed keywords

ADMINISTRATIVE PERSONNEL; ADULT; COST CONTROL; ECONOMIC ASPECT; HEALTH CARE MANAGEMENT; HUMAN; INTENSIVE CARE; INTENSIVE CARE UNIT; MEDICAL EDUCATION; MEDICAL SOCIETY; PATIENT CARE; PATIENT SAFETY; PHARMACIST; REVIEW;

HUMANS; INTENSIVE CARE; INTENSIVE CARE UNITS; INTERDISCIPLINARY COMMUNICATION; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT CARE TEAM; PHARMACISTS; PHARMACY SERVICE, HOSPITAL;

EID: 79551580806     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.31.2.128     Document Type: Review

References (31)

1. Page RL, Hume AL, Trujillo JM, et al, for the American College of Clinical Pharmacy. Interprofessional education: principles and application - a framework for clinical pharmacy [online exclusive article]. Pharmacotherapy 2009;29:e1453-64. Available from www.pharmacotherapy.org.
2. Mitchell PH. What's in a name? Multidisciplinary, interdisciplinary, and transdisciplinary. J Prof Nurs 2005;21:332-4.
3. Society of Critical Care Medicine. History of the CPP specialty section. Available from http://www.sccm.org/Membership/Specialty-Sections/Pharmacy-and- Pharmacology/Pages/HistoryofCPPSpecialtySection.aspx. Accessed April 9, 2010.
4. Weil MH. The Society of Critical Care Medicine, its history and destiny. Crit Care Med 1973;1:1-4.
5. Task Force on Guidelines, Society of Critical Care Medicine. Recommendations for services and personnel for delivery of care in a critical care setting. Crit Care Med 1988;16:809-11.
6. American College of Critical Care Medicine of the Society of Critical Care Medicine. Critical care services and personnel: recommendations based on a system of categorization into two levels of care. Crit Care Med 1999;27:422-6.
7. Rudis MI, Brandl KM, for the Society of Critical Care Medicine and American College of Clinical Pharmacy Task Force on Critical Care Pharmacy Services. Position paper on critical care pharmacy services. Crit Care Med 2000;28:3746-50.
8. Brilli RJ, Spevetz A, Branson RD, et al. Critical care delivery in the intensive care unit: defining clinical roles and the best practice model. Crit Care Med 2001;29:2007-19.
9. Michaels AD, Spinler SA, Leeper B, et al, on behalf of the American Heart Association Acute Cardiac Care Committee of the Council of Clinical Cardiology, Council on Quality of Care and Outcomes Research; Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation; Council on Cardiovascular Nursing; and Stroke Council. Medication errors in acute cardiovascular and stroke patients: a scientific statement from the American Heart Association. Circulation 2010;121:1-19.
10. Reader TW, Flin R, Mearns K, Cuthbertson BH. Developing a team performance framework for the intensive care unit. Crit Care Med 2009;37:1787-93.
11. Dodek PM, Raboud J. Explicit approach to rounds in an ICU improves communication and satisfaction of providers. Intensive Care Med 2003;29:1584-8. (Pubitemid 37153605)
12. Reader TW, Flin R, Mearns K, Cuthbertson BH. Interdisciplinary communication in the intensive care unit. Br J Anesth 2007;98:347-52. (Pubitemid 47072673)
13. Curtis RJ, Cook DJ, Wall RJ, et al. Intensive care unit quality improvement: a "how-to" guide for the interdisciplinary team. Crit Care Med 2006;34:211-18.
14. Durbin CG. Team model: advocating for the optimal method of care delivery in the intensive care unit. Crit Care Med 2006;34(suppl):S12-17.
15. Kim MM, Barnato AE, Angus DC, Fleisher LF, Kahn JM. The effect of multidisciplinary care teams on intensive care unit mortality. Arch Intern Med 2010;170:369-76.
16. Cobb JP. Engineering health in the intensive care unit. Arch Intern Med 2010;170:319-20.
17. Jain M, Miller L, Belt D, King D, Berwick DM. Decline in ICU adverse events, nosocomial infections and cost through a quality improvement initiative focusing on teamwork and culture change. Qual Saf Health Care 2006;15:235-9. (Pubitemid 44238303)
18. Cardarelli M, Vaidya V, Conway D, Jarin J, Xiao Y. Dissecting multidisciplinary cardiac surgery rounds. Ann Thorac Surg 2009;88:809-13.
19. Manser T. Teamwork and patient safety in dynamic domains of healthcare: a review of the literature. Acta Anaesthesiol Scand 2009;53:143-51.
20. Shojania KG, Duncan BW, McDonald KM, et al, eds. Making health care safer: a critical analysis of safety practices. Evidence report/technology assessment no. 43 (prepared by the University of California at San Francisco - Stanford University Evidence-Based Practice Center under contract no. 290-97-0013), AHRQ publication no. 01-E058. Rockville, MD: Agency for Healthcare Research and Quality, July 2001.
21. Leape LL, Cullen DJ, Clapp MD, et al. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. JAMA 1999;282:267-70.
22. Leape LL, Berwick DM, Bates DW. What practices will most improve safety? Evidence-based medicine meets practice safety. JAMA 2002;288:501-3.
23. Erstad BL, Brophy GM, Martin SJ, et al. Key articles and guidelines relative to intensive care unit pharmacotherapy: 2009 update. Pharmacotherapy 2009;29:1228-69.
24. De Rijdt T, Willems L, Simoens S. Economic effects of clinical pharmacy interventions: a literature review. Am J Health Syst Pharm 2008;65:1161-72. (Pubitemid 351874860)
25. Kaye J, Ashline V, Erickson D, et al. Critical care bug team: a multidisciplinary approach to reducing ventilator-associated pneumonia. Am J Infect Control 2000;28:197-201.
26. Ng TMH, Bell AM, Hong C, et al. Pharmacist monitoring of QTc interval-prolonging medications in critically ill medical patients: a pilot study. Ann Pharmacother 2008;42:475-82. (Pubitemid 351521960)
27. MacLaren R, Bond CA, Martin SJ, Fike D. Clinical and economic outcomes involving pharmacists in the direct care of critically ill patients with infections. Crit Care Med 2008;36:3184-9.
28. Kalina M, Tinkoff G, Gleason W, Veneri P, Fulda G. A multidisciplinary approach to adverse drug events in pediatric trauma patients in an adult trauma center. Pediatr Emer Care 2009;25:444-6.
29. Weant KA, Armistead JA, Ladha AM, Sasaki-Adams D, Hadar EJ, Ewend MG. Cost effectiveness of a clinical pharmacist on a neurosurgical team. Neurosurgery 2009;65:946-51.
30. MacLaren R, Devlin JW, Martin SJ, Dasta JF, Rudis MI, Bond CA. Critical care pharmacy services in United States hospitals. Ann Pharmacother 2006;40:612-18.
31. Dasta JF, Segal R, Cunningham A. A national survey of critical care pharmaceutical services. Am J Hosp Pharm 1989;46:2308-12. (Pubitemid 19284593)